News

Ask Alzheimer's Patient Caregiver: Patch or Pill Therapy?

Publish date: April 6, 2012

 

EXPERT ANALYSIS FROM A PSYCHOPHARMACOLOGY CONFERENCE SPONSORED BY THE NEVADA PSYCHIATRIC ASSOCIATION

Dr. Cummings disclosed that he has provided consultation to the following pharmaceutical companies: Abbott, Acadia, Adamas, Anavex, Astellas, Avanir, Bayer, BMS, Eisai, EnVivo, ExonHit, Janssen, Forest, Genentech, GSK, Lundbeck, Merck, Neurokos, Novartis, Otsuka, Pfizer, Prana, QR Pharma, Sanofi-Aventis, and Takeda.

Pages

Recommended Reading

Scan That Predicts Alzheimer's Creates Moral Dilemma
MDedge Psychiatry
Continuing Donepezil Appears Best for Some Alzheimer's Patients
MDedge Psychiatry
Asymptomatic Carotid Disease Impairs Cognitive Function
MDedge Psychiatry
Pain Medications Relieve Agitation in Demented Patients
MDedge Psychiatry
Monitoring Antipsychotic Side Effects Infrequent Among Dementia Patients
MDedge Psychiatry
Delirium Due to Medical Cause Often Misdiagnosed as Psychiatric Disorder
MDedge Psychiatry
Single Question Flags Depression in Chronic Pain
MDedge Psychiatry
Diabetes Managed More Tightly in Demented Patients
MDedge Psychiatry
Asymptomatic Neurocognitive Impairment Quantified in HIV-Positive Patients
MDedge Psychiatry
New Alzheimer’s disease guidelines: Implications for clinicians
MDedge Psychiatry